<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:efc183d7-0f42-4323-b048-d0cbf1b6704c,g:8427eb94-f5e8-4f7f-9388-e342e977991c,d:5558465a26814f81915a37bac1c80bf9--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mdxg-20210503</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV80L2ZyYWc6NWQxMjExYzc3NDA5NDlmNGE4Y2ExNTczMzIwYjYxYmQvdGFibGU6NTQ1NDNiODQzNDk0NDdlZjg5NDUzNDM5OGUzZTMwZjcvdGFibGVyYW5nZTo1NDU0M2I4NDM0OTQ0N2VmODk0NTM0Mzk4ZTNlMzBmN18yLTEtMS0xLTA_f7269880-c2b6-415a-8388-f801402de181">0001376339</ix:nonNumeric><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV80L2ZyYWc6NWQxMjExYzc3NDA5NDlmNGE4Y2ExNTczMzIwYjYxYmQvdGFibGU6NTQ1NDNiODQzNDk0NDdlZjg5NDUzNDM5OGUzZTMwZjcvdGFibGVyYW5nZTo1NDU0M2I4NDM0OTQ0N2VmODk0NTM0Mzk4ZTNlMzBmN180LTEtMS0xLTA_372deedd-23f2-4f73-b1a4-f3cb8415da99">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mdxg-20210503.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ie52afe1459ab494bbe922dd765286594_D20210503-20210503"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001376339</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-03</xbrli:startDate><xbrli:endDate>2021-05-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5558465a26814f81915a37bac1c80bf9_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, DC 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzM5_4b1a9299-1718-406d-8b72-af0ab7ebe875">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yNjY_7522a4e0-b7e0-4cf3-b168-24b7b6ca9bbf">May 3, 2021</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzM2_d19e8f03-90dd-4d6e-bb92-2dc48679c170">MIMEDX GROUP, INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.539%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.305%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.542%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6ZTA5NDhlMzZjMWJjNGZhMjhkODZkM2NmZjZlNjFiNGEvdGFibGVyYW5nZTplMDk0OGUzNmMxYmM0ZmEyOGQ4NmQzY2ZmNmU2MWI0YV8wLTAtMS0xLTA_00bf1ec2-18bb-427e-8239-4463f43e9996">Florida</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6ZTA5NDhlMzZjMWJjNGZhMjhkODZkM2NmZjZlNjFiNGEvdGFibGVyYW5nZTplMDk0OGUzNmMxYmM0ZmEyOGQ4NmQzY2ZmNmU2MWI0YV8wLTItMS0xLTA_d29d1c44-02f7-444d-94cb-55052eac1cfd">001-35887</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6ZTA5NDhlMzZjMWJjNGZhMjhkODZkM2NmZjZlNjFiNGEvdGFibGVyYW5nZTplMDk0OGUzNmMxYmM0ZmEyOGQ4NmQzY2ZmNmU2MWI0YV8wLTQtMS0xLTA_7ba62e9b-73ea-4d39-8b4b-c159e69c9f9d">26-2792552</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(State or other jurisdiction</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Commission</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(IRS Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">of incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">File Number)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzQw_95b5ed40-485b-429e-8062-1d467ea02273">1775 West Oak Commons Ct., NE</ix:nonNumeric>, <ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzQx_9ed89eee-3c69-43e9-b468-ff841b042aab">Marietta</ix:nonNumeric> <ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzQy_01f74fe9-f002-4061-9aaf-71ba2315d146">GA</ix:nonNumeric> <ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzM3_ca49412b-b343-4267-bc84-9e91e12664ab">30062</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzM4_499d54f2-788b-4d31-bcab-4f2ab3df7402">770</ix:nonNumeric>) <ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzQz_89d88d34-0a1e-4e9f-a39b-32838cb82692">651-9100</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">____________________</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.432%"><tr><td style="width:0.1%"></td><td style="width:2.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.028%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6ZjAxMDZmY2M2NzdjNGUwMzhjMThkYWMwOTY5ZjhiOWIvdGFibGVyYW5nZTpmMDEwNmZjYzY3N2M0ZTAzOGMxOGRhYzA5NjlmOGI5Yl8wLTAtMS0xLTA_8e2bc525-4393-4908-9a55-6655fc46bc8d">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6ZjAxMDZmY2M2NzdjNGUwMzhjMThkYWMwOTY5ZjhiOWIvdGFibGVyYW5nZTpmMDEwNmZjYzY3N2M0ZTAzOGMxOGRhYzA5NjlmOGI5Yl8xLTAtMS0xLTA_06da1aba-2d5e-413d-9b13-0cdd5bf71eb2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6ZjAxMDZmY2M2NzdjNGUwMzhjMThkYWMwOTY5ZjhiOWIvdGFibGVyYW5nZTpmMDEwNmZjYzY3N2M0ZTAzOGMxOGRhYzA5NjlmOGI5Yl8yLTAtMS0xLTA_d8bd4907-63d3-408e-9161-7639f5f82c4f">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6ZjAxMDZmY2M2NzdjNGUwMzhjMThkYWMwOTY5ZjhiOWIvdGFibGVyYW5nZTpmMDEwNmZjYzY3N2M0ZTAzOGMxOGRhYzA5NjlmOGI5Yl8zLTAtMS0xLTA_80c42e8f-a318-4b57-b902-34dac811092e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.350%"><tr><td style="width:1.0%"></td><td style="width:27.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.806%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange<br/>on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6YWM2OTM2ODdkNjE4NGVkNzhlMTY1ZTVkMTJmZGVhOTMvdGFibGVyYW5nZTphYzY5MzY4N2Q2MTg0ZWQ3OGUxNjVlNWQxMmZkZWE5M18xLTAtMS0xLTA_0ecf263a-afa8-4b29-866a-10e514f2a06b">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6YWM2OTM2ODdkNjE4NGVkNzhlMTY1ZTVkMTJmZGVhOTMvdGFibGVyYW5nZTphYzY5MzY4N2Q2MTg0ZWQ3OGUxNjVlNWQxMmZkZWE5M18xLTItMS0xLTA_c975e462-77de-4ee6-8b44-02e8f42ab2e9">MDXG</ix:nonNumeric></span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGFibGU6YWM2OTM2ODdkNjE4NGVkNzhlMTY1ZTVkMTJmZGVhOTMvdGFibGVyYW5nZTphYzY5MzY4N2Q2MTg0ZWQ3OGUxNjVlNWQxMmZkZWE5M18xLTQtMS0xLTA_20952857-4667-4020-bdc0-44ea6d6d762b">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167; 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167; 240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie52afe1459ab494bbe922dd765286594_D20210503-20210503" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjU1NTg0NjVhMjY4MTRmODE5MTVhMzdiYWMxYzgwYmY5L3NlYzo1NTU4NDY1YTI2ODE0ZjgxOTE1YTM3YmFjMWM4MGJmOV8xL2ZyYWc6NWEyOTUwM2YxZjc0NDcyZWE0M2IwYTlhZmIxMDA5MDcvdGV4dHJlZ2lvbjo1YTI5NTAzZjFmNzQ0NzJlYTQzYjBhOWFmYjEwMDkwN18yMzQ0_b97be936-0ae6-4232-80c3-2fba0768e732">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:72pt;text-align:justify;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01&#160;&#160;&#160;&#160;Regulation FD.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 3, 2021, MiMedx Group, Inc. (the "Company" or the "Registrant") issued a press release </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">announcing that it had filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with its 2021 Annual Meeting of Shareholders to be held virtually on May 27, 2021 at 10:00 a.m. Eastern Time at www.cesonlineservices.com/mdxg21_vm. The press release also announced that in conjunction with the definitive proxy filing, MiMedx has mailed a letter to shareholders detailing the decisive actions the Board and management team have taken to create shareholder value by transforming MiMedx into a stronger company that is well-positioned to capitalize on the growth opportunities in the regenerative medicine industry. MiMedx&#8217;s definitive proxy materials, letter to shareholders and other relevant information can be found at https://votemimedx.com/. The foregoing summary of the press release is qualified in its entirely by reference to the full text of the press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also on May 3, 2021, the Company published a letter to healthcare professionals regarding the expected effect of the end of the U.S. Food and Drug Administration's enforcement discretion. The letter explains that the FDA's actions apply to all companies and indicates which of the Company's products it expects to be affected. The foregoing summary of the letter is qualified in its entirely by reference to the full text of the letter which is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, MiMedx disclaims any inference regarding the materiality of such information which otherwise may arise as a result of its furnishing such information under Item 7.01 of this Current Report on Form 8-K. Information contained on the  website https://votemimedx.com/ is not incorporated by reference into this Current Report on Form 8-K. The information in the preceding paragraph, as well as Exhibit 99.1 and Exhibit 99.2, shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) or otherwise subject to the liabilities of that section. It may only be incorporated by reference into another filing under the Exchange Act or Securities Act of 1933 if such subsequent filing specifically references Section 7.01 of this Current Report on Form 8-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;Financial Statements and Exhibits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.017%"><tr><td style="width:1.0%"></td><td style="width:12.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.047%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991pressreleasetomay32021.htm">Press Release dated May 3, 2021</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex992lettertohealthcarepro.htm">Letter to Healthcare Professionals dated May 3, 2021.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.</span></td></tr></table></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center"><span><br/></span></div><div style="padding-left:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </span></div><div style="padding-left:4.5pt"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"></td><td style="width:45.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.975%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.027%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MIMEDX GROUP, INC.</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: May 3, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Peter M. Carlson</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peter M. Carlson<br/>Chief Financial Officer</span></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "mdxg-20210503.htm", "description": "8-K", "secsgml_size_bytes": 35731}]
{"company-data": {"conformed-name": "MIMEDX GROUP, INC.", "cik": "0001376339", "assigned-sic": "3841", "irs-number": "262792552", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-35887", "film-number": "21881380"}, "business-address": {"street1": "1775 W OAK COMMONS COURT, NE", "city": "MARIETTA", "state": "GA", "zip": "30062", "phone": "(770) 651-9100"}, "mail-address": {"street1": "1775 W OAK COMMONS COURT, NE", "city": "MARIETTA", "state": "GA", "zip": "30062"}, "former-company": {"former-conformed-name": "Alynx, Co.", "date-changed": "20060922"}}
mdxg-20210503
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
____________________
FORM
8-K
____________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
May 3, 2021
MIMEDX GROUP, INC.
(Exact name of registrant as specified in charter)
Florida
001-35887
26-2792552
(State or other jurisdiction
(Commission
(IRS Employer
of incorporation)
File Number)
Identification No.)
1775 West Oak Commons Ct., NE
,
Marietta
GA
30062
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (
770
)
651-9100
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange
on which registered
Common Stock, $0.001 par value per share
MDXG
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01    Regulation FD.
On May 3, 2021, MiMedx Group, Inc. (the "Company" or the "Registrant") issued a press release
announcing that it had filed definitive proxy materials with the U.S. Securities and Exchange Commission in connection with its 2021 Annual Meeting of Shareholders to be held virtually on May 27, 2021 at 10:00 a.m. Eastern Time at www.cesonlineservices.com/mdxg21_vm. The press release also announced that in conjunction with the definitive proxy filing, MiMedx has mailed a letter to shareholders detailing the decisive actions the Board and management team have taken to create shareholder value by transforming MiMedx into a stronger company that is well-positioned to capitalize on the growth opportunities in the regenerative medicine industry. MiMedx's definitive proxy materials, letter to shareholders and other relevant information can be found at https://votemimedx.com/. The foregoing summary of the press release is qualified in its entirely by reference to the full text of the press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Also on May 3, 2021, the Company published a letter to healthcare professionals regarding the expected effect of the end of the U.S. Food and Drug Administration's enforcement discretion. The letter explains that the FDA's actions apply to all companies and indicates which of the Company's products it expects to be affected. The foregoing summary of the letter is qualified in its entirely by reference to the full text of the letter which is furnished as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated by reference herein.
In addition, MiMedx disclaims any inference regarding the materiality of such information which otherwise may arise as a result of its furnishing such information under Item 7.01 of this Current Report on Form 8-K. Information contained on the  website https://votemimedx.com/ is not incorporated by reference into this Current Report on Form 8-K. The information in the preceding paragraph, as well as Exhibit 99.1 and Exhibit 99.2, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section. It may only be incorporated by reference into another filing under the Exchange Act or Securities Act of 1933 if such subsequent filing specifically references Section 7.01 of this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No.
Description of Exhibit
99.1
Press Release dated May 3, 2021
.
99.2
Letter to Healthcare Professionals dated May 3, 2021.
104
The cover page from this Current Report on Form 8-K, formatted in Inline XBRL.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
MIMEDX GROUP, INC.
Date: May 3, 2021
By:
/s/ Peter M. Carlson
Peter M. Carlson
Chief Financial Officer